Article Versions Notes

van Veelen A, Küçük IT, Fuentes FH, Kahsay Y, Garcia-Garcia HM, Delewi R, Beijk MAM, den Hartog AW, Grundeken MJ, Vis MM, et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. Journal of Clinical Medicine. 2023; 12(18):5807. https://doi.org/10.3390/jcm12185807

van Veelen, Anna, I. Tarik Küçük, Federico H. Fuentes, Yirga Kahsay, Hector M. Garcia-Garcia, Ronak Delewi, Marcel A. M. Beijk, Alexander W. den Hartog, Maik J. Grundeken, M. Marije Vis, and et al. 2023. "First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study" Journal of Clinical Medicine 12, no. 18: 5807. https://doi.org/10.3390/jcm12185807

van Veelen, A., Küçük, I. T., Fuentes, F. H., Kahsay, Y., Garcia-Garcia, H. M., Delewi, R., Beijk, M. A. M., den Hartog, A. W., Grundeken, M. J., Vis, M. M., Henriques, J. P. S., & Claessen, B. E. P. M. (2023). First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. Journal of Clinical Medicine, 12(18), 5807. https://doi.org/10.3390/jcm12185807